Article
Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy.
The American journal of pathology - 1 May 2016
Kuraoka Mutsuki, Kimura En, Nagata Tetsuya, Okada Takashi, Aoki Yoshitsugu, Tachimori Hisateru, Yonemoto Naohiro, Imamura Michihiro, Takeda Shin'ichi
Abstract excerpt
Duchenne muscular dystrophy is a lethal X-linked muscle disorder. We have already reported that osteopontin (OPN), an inflammatory cytokine and myogenic factor, is expressed in the early dystrophic phase in canine X-linked muscular dystrophy in Japan, a dystrophic dog model. To further explore the possibility of OPN as a new biomarker for disease activity in Duchenne muscular dystrophy, we monitored serum OPN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
